Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Venky's (India) has informed that the company is setting up a new project for manufacture of Veterinary Medicine Products under its Animal Health Product Segment. The Company has acquired land admeasuring 15030 Sqm at MIDC, Village: Kesurdi, Tal: Khandala, District: Satara, Maharashtra for this purpose. Construction activities will commence in December 2021 and it is expected that the project will be completed by March 2022 and commercial production will commence by June 2022. This project is to manufacture Veterinary Medicines Powders (600 Tonnes/Annum) and Veterinary Medicines Liquids (300 Kilolitres / Annum) to cater the growing demand from poultry industry. Total cost of the project is estimated at Rs. 30.00 Crs. which will be funded from internal accruals.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Venkys India | 1595.00 |
| Mangalam Global Ent | 14.39 |
| Kaveri Seed | 945.80 |
| Regaal Resources | 85.34 |
| Simran Farms | 170.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: